1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Fibrocystic Breasts Diagnostics and Treatment Market, By Type
5.1 Introduction
5.2 Breast Biopsy
5.3 Nonsteroidal Anti Inflammatory Drugs
5.4 Acetaminophen
5.5 Oral Contraceptives
5.6 Other Types
6 Global Fibrocystic Breasts Diagnostics and Treatment Market, By End User
6.1 Introduction
6.2 Diagnostic Centers
6.3 Hospitals
6.4 Research Institutes
6.5 Specialty Clinics and Rehab Centers
6.6 Other End Users
7 Global Fibrocystic Breasts Diagnostics and Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Argon Medical Devices
9.2 Boston Scientific
9.3 CareFusion Corporation
9.4 Cook Medical, INRAD, Inc
9.5 Devicor Medical Products Inc
9.6 Allergan plc
9.7 Bayer AG
9.8 Teva Pharmaceutical Industries Ltd
9.9 Merck & Co., Inc
9.10 Gallini Medical Devices
9.11 Pfizer Inc
List of Tables
Table 1 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 4 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 5 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 6 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 7 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 8 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 9 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 10 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 11 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 12 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 13 Global Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Table 14 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Country (2021-2030) ($MN)
Table 15 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 16 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 17 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 18 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 19 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 20 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 21 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 22 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 23 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 24 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 25 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 26 North America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Table 27 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Country (2021-2030) ($MN)
Table 28 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 29 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 30 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 31 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 32 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 33 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 34 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 35 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 36 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 37 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 38 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 39 Europe Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Table 40 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Country (2021-2030) ($MN)
Table 41 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 42 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 43 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 44 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 45 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 46 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 47 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 48 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 49 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 50 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 51 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 52 Asia Pacific Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Table 53 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Country (2021-2030) ($MN)
Table 54 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 55 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 56 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 57 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 58 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 59 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 60 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 61 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 62 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 63 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 64 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 65 South America Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
Table 66 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Country (2021-2030) ($MN)
Table 67 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 68 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Breast Biopsy (2021-2030) ($MN)
Table 69 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Nonsteroidal Anti Inflammatory Drugs (2021-2030) ($MN)
Table 70 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Acetaminophen (2021-2030) ($MN)
Table 71 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Oral Contraceptives (2021-2030) ($MN)
Table 72 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other Types (2021-2030) ($MN)
Table 73 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By End User (2021-2030) ($MN)
Table 74 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
Table 75 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
Table 76 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 77 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Specialty Clinics and Rehab Centers (2021-2030) ($MN)
Table 78 Middle East & Africa Fibrocystic Breasts Diagnostics and Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 線維嚢胞性乳房は、多くの女性に見られる乳腺組織の変化であり、一般的には良性の病態とされています。線維腺腫と嚢胞が共存し、乳房にしこりや痛みを引き起こすことがあります。この状態は、月経周期に伴うホルモン変動に関連しており、特に30代から50代の女性に多く見られます。 診断の際には、まず乳房のしこりや腫れを触診し、その後、画像診断が行われます。マンモグラフィーや超音波検査が主に用いられ、これによりしこりの性質を確認します。必要に応じて、細胞診や組織診断も行われ、悪性腫瘍との鑑別が重要です。 線維嚢胞性乳房は主に二つのタイプに分けられます。一つは、嚢胞が多発するタイプで、これにより乳房が腫れたり、圧痛を伴うことがあります。もう一つは、線維腺腫が主体になるタイプで、しこりが固く感じられることが特徴です。これらの型は、症状や触診所見によって診断されますが、確定診断には画像診断や生検が必要です。 治療に関しては、多くの場合、特に症状が軽度である場合には特別な治療が必要ないことが多いです。定期的なフォローアップが行われ、症状の経過を観察します。しかし、痛みが強い場合や日常生活に支障をきたす場合には、治療が考慮されます。一般的な治療方法には、鎮痛剤の使用、ホルモン療法、嚢胞の針吸引などがあります。 ホルモン療法は、女性ホルモンのバランスを整えることで症状を緩和することを目的としています。ピルの使用やホルモン補充療法が適応されることもあります。また、嚢胞が大きくなって痛みを伴う場合には、針吸引によって液体を取り除く治療が有効です。これにより、症状が軽減されることが多いです。 関連技術としては、画像診断技術が大きな役割を果たしています。特に超音波検査は、乳房の嚢胞やしこりの特性を判断する上で非常に有効な手段です。さらに、マグネット共鳴画像( MRI) も近年利用されるようになってきており、より詳細な情報を得ることが可能です。これらの診断技術の進歩により、早期発見や適切な治療が可能になっています。 線維嚢胞性乳房は、社会的なコンディションや食生活、遺伝的要因などが影響を与えると考えられています。そのため、予防策としては、健康的な食生活や定期的な運動、ストレス管理が推奨されます。定期的な乳房自己検査や、定期的な医療機関でのチェックを行うことで、早期発見につながる可能性が高まります。 総じて、線維嚢胞性乳房は一般的には良性の状態であり、多くの女性が悩む症状ですが、しっかりとした診断と適切な治療を受けることで、生活の質を向上させることができます。注意が必要なのは、しこりや痛みが続く場合、自己判断せずに専門の医療機関での診断を受けることです。これにより、安心して日常を過ごすことができるようになります。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
